Nan Fung Trinity HK Ltd. Takes $23.21 Million Position in GE HealthCare Technologies Inc. $GEHC

Nan Fung Trinity HK Ltd. bought a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 309,000 shares of the company’s stock, valued at approximately $23,206,000. GE HealthCare Technologies accounts for approximately 2.3% of Nan Fung Trinity HK Ltd.’s holdings, making the stock its 14th biggest position.

A number of other large investors have also recently bought and sold shares of GEHC. Allianz SE raised its stake in GE HealthCare Technologies by 165.2% during the second quarter. Allianz SE now owns 350 shares of the company’s stock worth $26,000 after acquiring an additional 218 shares in the last quarter. E Fund Management Hong Kong Co. Ltd. grew its holdings in shares of GE HealthCare Technologies by 130.7% in the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock worth $26,000 after purchasing an additional 196 shares during the last quarter. Godsey & Gibb Inc. acquired a new stake in shares of GE HealthCare Technologies during the 3rd quarter worth about $26,000. Gladwyn Financial Advisors Inc. bought a new position in GE HealthCare Technologies during the 2nd quarter valued at about $34,000. Finally, Piscataqua Savings Bank boosted its position in GE HealthCare Technologies by 173.4% in the third quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock valued at $36,000 after buying an additional 300 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

GEHC has been the subject of a number of research analyst reports. UBS Group cut shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and lifted their target price for the company from $73.00 to $77.00 in a research note on Thursday, January 15th. Jefferies Financial Group boosted their price objective on GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a research note on Thursday, December 11th. Wells Fargo & Company lowered their target price on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating for the company in a research note on Thursday, October 30th. Piper Sandler upped their price target on shares of GE HealthCare Technologies from $91.00 to $94.00 and gave the stock an “overweight” rating in a research report on Friday. Finally, Bank of America increased their price objective on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a report on Monday, January 5th. Seven research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Hold” and a consensus target price of $90.33.

GE HealthCare Technologies Trading Up 0.2%

Shares of NASDAQ GEHC opened at $78.97 on Friday. The company’s 50 day simple moving average is $82.63 and its 200 day simple moving average is $77.35. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.18 and a quick ratio of 0.95. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The firm has a market capitalization of $35.97 billion, a P/E ratio of 16.32, a P/E/G ratio of 2.38 and a beta of 1.08.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. The company had revenue of $5.14 billion during the quarter, compared to analysts’ expectations of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.GE HealthCare Technologies’s revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the business posted $1.14 EPS. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be given a $0.035 dividend. The ex-dividend date is Friday, January 9th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 2.89%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.